| |
| |
|
| Insider
Information: |
Ray Debanjan |
| Relationship: |
Chief Financial Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,928 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytomx Therapeutics, Inc. |
CTMX |
Chief Financial Officer |
2018-12-12 |
5,928 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
AS |
$15.00 |
$45,000 |
D/D |
(3,000) |
5,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
OE |
$1.45 |
$4,347 |
D/D |
3,000 |
8,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-10-01 |
4 |
AS |
$18.46 |
$55,380 |
D/D |
(3,000) |
5,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-10-01 |
4 |
OE |
$1.45 |
$4,347 |
D/D |
3,000 |
8,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-09-04 |
4 |
AS |
$22.39 |
$67,170 |
D/D |
(3,000) |
5,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-09-04 |
4 |
OE |
$1.45 |
$4,347 |
D/D |
3,000 |
8,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-08-01 |
4 |
AS |
$26.05 |
$78,150 |
D/D |
(3,000) |
5,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-08-01 |
4 |
OE |
$1.26 |
$3,835 |
D/D |
3,000 |
8,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-07-02 |
4 |
OE |
$1.26 |
$3,780 |
D/D |
3,000 |
8,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-07-02 |
4 |
AS |
$22.56 |
$67,680 |
D/D |
(3,000) |
5,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-06-01 |
4 |
AS |
$25.93 |
$77,793 |
D/D |
(3,000) |
5,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-06-01 |
4 |
OE |
$1.26 |
$3,780 |
D/D |
3,000 |
8,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-05-31 |
4 |
A |
$17.90 |
$21,248 |
D/D |
1,187 |
5,928 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-05-01 |
4 |
AS |
$26.52 |
$79,562 |
D/D |
(3,000) |
4,741 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-05-01 |
4 |
OE |
$1.26 |
$3,780 |
D/D |
3,000 |
7,741 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-04-02 |
4 |
AS |
$28.12 |
$84,360 |
D/D |
(3,000) |
4,741 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-04-02 |
4 |
OE |
$1.26 |
$3,780 |
D/D |
3,000 |
7,741 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-03-02 |
4 |
AS |
$30.06 |
$607,453 |
D/D |
(20,000) |
4,741 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-03-02 |
4 |
OE |
$1.13 |
$23,373 |
D/D |
20,000 |
19,226 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-03-01 |
4 |
AS |
$29.40 |
$382,242 |
D/D |
(13,000) |
4,741 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-03-01 |
4 |
OE |
$1.26 |
$16,379 |
D/D |
13,000 |
17,741 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-02-01 |
4 |
AS |
$26.69 |
$68,010 |
D/D |
(2,548) |
4,741 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-01-02 |
4 |
AS |
$21.11 |
$52,775 |
D/D |
(2,500) |
7,289 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-12-01 |
4 |
AS |
$20.58 |
$51,450 |
D/D |
(2,500) |
9,789 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-11-30 |
4 |
A |
$12.15 |
$1,980 |
D/D |
163 |
12,289 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
